203 related articles for article (PubMed ID: 7945743)
1. Plasma clozapine and desmethylclozapine levels in clozapine-induced agranulocytosis.
Hasegawa M; Cola PA; Meltzer HY
Neuropsychopharmacology; 1994 Aug; 11(1):45-7. PubMed ID: 7945743
[TBL] [Abstract][Full Text] [Related]
2. N-desmethylclozapine, an insensitive marker of clozapine-induced agranulocytosis and granulocytopenia.
Combs MD; Perry PJ; Bever KA
Pharmacotherapy; 1997; 17(6):1300-4. PubMed ID: 9399615
[TBL] [Abstract][Full Text] [Related]
3. N-desmethylclozapine: a clozapine metabolite that suppresses haemopoiesis.
Gerson SL; Arce C; Meltzer HY
Br J Haematol; 1994 Mar; 86(3):555-61. PubMed ID: 8043437
[TBL] [Abstract][Full Text] [Related]
4. Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.
Smith RL; Haslemo T; Andreassen OA; Eliasson E; Dahl ML; Spigset O; Molden E
CNS Drugs; 2017 Nov; 31(11):991-997. PubMed ID: 28948574
[TBL] [Abstract][Full Text] [Related]
5. Neuroleptic-resistant schizophrenic patients treated by clozapine: clinical evolution, plasma and red blood cell clozapine and desmethylclozapine levels.
Aymard N; Baldacci C; Leyris A; Smagghe PO; Tribolet S; Vacheron MN; Viala A; Caroli F
Therapie; 1997; 52(3):227-32. PubMed ID: 9366107
[TBL] [Abstract][Full Text] [Related]
6. Clozapine-associated agranulocytosis: risk and aetiology.
Krupp P; Barnes P
Br J Psychiatry Suppl; 1992 May; (17):38-40. PubMed ID: 1418887
[TBL] [Abstract][Full Text] [Related]
7. Clozapine treatment after agranulocytosis induced by classic neuroleptics.
Bauer M; Mackert A
J Clin Psychopharmacol; 1994 Feb; 14(1):71-3. PubMed ID: 7908676
[TBL] [Abstract][Full Text] [Related]
8. Agranulocytosis during clozapine therapy.
Gaszner P; Makkos Z; Kosza P
Prog Neuropsychopharmacol Biol Psychiatry; 2002 Apr; 26(3):603-7. PubMed ID: 11999915
[TBL] [Abstract][Full Text] [Related]
9. Late-onset agranulocytosis in a patient with schizophrenia after 17 months of clozapine treatment.
Bhanji NH; Margolese HC; Chouinard G; Turnier L
J Clin Psychopharmacol; 2003 Oct; 23(5):522-3. PubMed ID: 14520134
[No Abstract] [Full Text] [Related]
10. Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors.
Pollmächer T; Hinze-Selch D; Mullington J; Holsboer F
Arch Gen Psychiatry; 1995 Oct; 52(10):877-8. PubMed ID: 7575109
[No Abstract] [Full Text] [Related]
11. [Hematologic effects of clozapine: evaluation of the international experience].
Lamarque V
Encephale; 1995 Jun; 21 Spec No 3():59-60. PubMed ID: 7628344
[TBL] [Abstract][Full Text] [Related]
12. Clozapine-induced agranulocytosis after 11 years of treatment.
Sedky K; Shaughnessy R; Hughes T; Lippmann S
Am J Psychiatry; 2005 Apr; 162(4):814. PubMed ID: 15800170
[No Abstract] [Full Text] [Related]
13. [Clozapine screening: white bloodcell counts no longer sufficient].
Cohen D;
Tijdschr Psychiatr; 2010; 52(11):785-90. PubMed ID: 21064021
[TBL] [Abstract][Full Text] [Related]
14. Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.
Fabrazzo M; Esposito G; Fusco R; Maj M
Psychopharmacology (Berl); 1996 Mar; 124(1-2):197-200. PubMed ID: 8935816
[TBL] [Abstract][Full Text] [Related]
15. Psychopharmacology. Clozapine and agranulocytosis.
Feldman J
Psychiatr Serv; 1996 Nov; 47(11):1177-8. PubMed ID: 8916231
[No Abstract] [Full Text] [Related]
16. Long-term combination treatment with clozapine and filgrastim in patients with clozapine-induced agranulocytosis.
Hägg S; Rosenius S; Spigset O
Int Clin Psychopharmacol; 2003 May; 18(3):173-4. PubMed ID: 12702898
[TBL] [Abstract][Full Text] [Related]
17. [A case study; ethnicity and clozapine, a risky combination?].
Laan WJ; Ramlal D
Tijdschr Psychiatr; 2012; 54(9):829-33. PubMed ID: 22961282
[TBL] [Abstract][Full Text] [Related]
18. High clozapine concentrations in leukocytes in a patient who developed leukocytopenia.
Bergemann N; Abu-Tair F; Aderjan R; Kopitz J
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1068-71. PubMed ID: 17467133
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of clozapine in treatment-refractory schizophrenia: an overview.
Kane JM
Br J Psychiatry Suppl; 1992 May; (17):41-5. PubMed ID: 1418888
[TBL] [Abstract][Full Text] [Related]
20. Add-on filgrastim during clozapine rechallenge unsuccessful in preventing agranulocytosis.
Hazewinkel AW; Bogers JP; Giltay EJ
Gen Hosp Psychiatry; 2013; 35(5):576.e11-2. PubMed ID: 23395419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
